CVS Health Exceeds Third Quarter Estimates and Announces Strategic Split into Two Companies
CVS Health Corporation reported strong third-quarter results, with adjusted earnings per share (EPS) of $2.09 significantly outperforming analyst estimates of $1.65. Revenue grew 5.4% year-over-year to $108.4 billion, surpassing consensus expectations. Driven by these results, the company raised its full-year 2026 adjusted EPS guidance and substantially increased its cash flow guidance to at least $15.5 billion. In a major strategic shift, CVS Health announced plans to split into two independent, publicly traded companies by the first half of 2028. The separation aims to create a healthcare solutions entity (including Aetna and Caremark) and a retail pharmacy/community healthcare entity. While financial performance was robust across all segments, shares saw slight premarket volatility following the announcement.
Coverage
- 3D SYSTEMS CORP - 10-Q Filing
- CVS Health Announces Plan to Split into Two Publicly Traded Companies by 2028
- CVS outlines separation in H1 2028 and projects at least $8.65 adjusted EPS in 2027
- CVS Health Announces Plan to Separate into Two Independent Publicly Traded Companies by 2028
- Premarket Market Analysis: Trump Media, Tesla, and Novo Nordisk Lead Volatility Following Election Results
- CVS Health Exceeds Third Quarter Estimates and Announces Strategic Split into Two Companies
- CVS Health Announces Plan to Split into Two Separate Public Companies by 2028
- CVS Health Reportedly Planning Split into Two Publicly Traded Companies